Table 1. Clinical characteristics of the study subjects.
| ATA | AERD | P-valuea | |
|---|---|---|---|
| N | 12 | 11 | − |
| Age (years)b | 53.4±14.0 | 42.6±14.8 | 0.089 |
| Gender (male, %) | 27.3 | 25.0 | 0.901 |
| Smoking status (smoker, %) | 9.1 | 8.3 | 0.865 |
| Height (cm)b | 159.6±10.3 | 164.0±10.4 | 0.317 |
| Weight (kg)b | 63.6±9.1 | 63.6±11.4 | 0.990 |
| Body mass index (kg m−2)b | 25.0±2.5 | 23.7±3.7 | 0.354 |
| Decline in FEV1 by aspirin provocation (%)b | 5.3±5.3 | 26.5±8.0 | <0.001 |
| Blood eosinophils (%)b | 8.3±17.4 | 6.8±4.7 | 0.785 |
| FEV1 (% predicted)b | 87.7±14.6 | 84.7±29.3 | 0.760 |
| PC20 methacholine (mg ml−1)b | 11.0±11.1 | 5.5±7.6 | 0.218 |
| Total IgE (IU ml−1)b | 175.0±279.7 | 391.3±463.2 | 0.191 |
| Skin test (positive, %) | 54.5 | 50.0 | 0.827 |
Abbreviations: AERD, aspirin-exacerbated respiratory disease; ATA, aspirin-tolerant asthma; FEV1, forced expiratory volume in 1 s; Ig, immunoglobulin.
a
The P-values were obtained using χ2 test and independent t-test.
b
Presented as mean±s.d.